Suchergebnisse - "Jänne, P A"

PubPharm (90)

1

Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Yu, H. | Baik, C. | Kim, D. | +21

2

Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Boiarsky, D. | Lydon, C. | Chambers, E. | +10

3

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Ricciuti, B. | Alessi, J. | Elkrief, A. | +29

4

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Passaro, A. | Leighl, N. | Blackhall, F. | +31

5

Osimertinib plus platinum-pemetrexed in newly diagnosed epidermal growth factor receptor mutation-positive advanced/metastatic non-small-cell lung cancer : safety run-in results from the FLAURA2 study

enthalten in: ESMO open | 2021

von Planchard, D. | Feng, P. | Karaseva, N. | +10

6

Managing cancer patients during the COVID-19 pandemic : an ESMO multidisciplinary expert consensus

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Curigliano, G. | Banerjee, S. | Cervantes, A. | +76

7

Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers : results from the Actionable Genome Consortium

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Li, B. | Janku, F. | Jung, B. | +28

8

Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Hanna, G. | Supplee, J. | Kuang, Y. | +5

9

CNS response to osimertinib in patients with T790M-positive advanced NSCLC : pooled data from two phase II trials

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Goss, G. | Tsai, C. | Shepherd, F. | +12

10

SELECT-2 : a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Soria, J. | Fülöp, A. | Maciel, C. | +16

1
2
3
4
5
6
7
8
9
Nächster »
[9]